Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 404041 - 404060 out of 495964 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Slovakia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg prášok na infúzny koncentrát | plc ifc 1x100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg prášok na infúzny koncentrát | plc ifc 1x160 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg prášok na koncentrát na infúzny roztok | plc ifc 1x100 mg (liek.inj.skl.jantár.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyoEuropeGmbH |
| Slovakia | (L01FE02) panitumumab | Vectibix 20 mg/ml infúzny koncentrát | con inf 1x20 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Slovakia | (L01FF03) durvalumab | IMFINZI 50 mg/ml koncentrát na infúzny roztok | con inf 1x10 ml/500 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Slovakia | (L01FF03) durvalumab | IMFINZI 50 mg/ml koncentrát na infúzny roztok | con inf 1x2,4 ml/120 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Slovakia | (L01FF04) avelumab | Bavencio 20 mg/ml infúzny koncentrát | con inf 1x10 ml/200 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V. |
| Slovakia | (L01FF05) atezolizumab | Tecentriq 1200 mg koncentrát na infúzny roztok | con inf 1x20 ml/1200 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheRegistrationGmbH |
| Slovakia | (L01FG01) bevacizumab | Abevmy 25 mg/ml koncentrát na infúzny roztok | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Slovakia | (L01FG01) bevacizumab | Abevmy 25 mg/ml koncentrát na infúzny roztok | con inf 1x4 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Slovakia | (L01FG01) bevacizumab | Avastin 25 mg/ml koncentrát na infúzny roztok | con inf 1x16 ml/400 mg (liek.inj.skl.) | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FG01) bevacizumab | Avastin 25 mg/ml koncentrát na infúzny roztok | con inf 1x4 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FG01) bevacizumab | MVASI 25 mg/ml infúzny koncentrát | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UC |
| Slovakia | (L01FG01) bevacizumab | MVASI 25 mg/ml infúzny koncentrát | con inf 1x4 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UC |
| Slovakia | (L01FG01) bevacizumab | VEGZELMA 25 mg/ml infúzny koncentrát | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionHealthcareHungaryKft. |
| Slovakia | (L01FG01) bevacizumab | VEGZELMA 25 mg/ml infúzny koncentrát | con inf 1x4 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionHealthcareHungaryKft. |
| Slovakia | (L01FG01) bevacizumab | Zirabev 25 mg/ml koncentrát na infúzny roztok | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerEuropeMAEEIG |
| Slovakia | (L01FX05) brentuximab vedotin | ADCETRIS 50 mg prášok na koncentrát na infúzny roztok | plc ifc 1x50 mg (liek. inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaA/S |
| Slovakia | (L01FX07) blinatumomab | BLINCYTO 38,5 mikrogramov prášok na prípravu infúzneho koncentrátu a roztok na prípravu infúzneho roztoku | pci ssi 1x38,5 µg + 10 ml solv. (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenEuropeB.V. |
| Slovakia | (L01FX14) polatuzumab vedotin | Polivy 140 mg prášok na koncentrát na infúzny roztok | plc ifc 1x140 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | RocheRegistrationGmbH |
Pages
